CNE100005D27
CNE100005D27
BIOCYTOGEN-B
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 |
|---|---|---|
Market & Enterprise Value | ||
Market Cap | 30.7B EUR | 20.73B EUR |
Enterprise Value | 30.57B EUR | 20.53B EUR |
Valuation Multiples | ||
Trailing P/E | 72.84x | -- |
Forward P/E | 45.13x | -- |
Price to Sales | 18.07x | -- |
Price to Book | 10.89x | 8.56x |
EV/Revenue | 17.99x | -- |
EV/EBITDA | 58.23x | -- |
Price to FCF (P/FCF) | 959.73x | -- |
EV/FCF | 955.73x | -- |
FCF Yield | 0.1% | -- |